Yomi Pharma Revenue
Biotechnology Research • 
Limoges, Nouvelle-Aquitaine, France • 1-10 Employees
$
Yomi Pharma revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Yomi Pharma
Camille Granet
Co-founder & CEO
Company overview
| Headquarters | Ester Technopole, 1 avenue d'ESTER, Limoges, Nouvelle-Aquitaine 87069, FR |
| NAICS | 541714 |
| Keywords | Biotechnology, Oncology, Lung Cancer, Therapies |
| Founded | 2023 |
| Employees | 1-10 |
About Yomi Pharma
Yomi Pharma is a young biotech company exploiting the natural properties of sortilin protein to develop innovative therapeutic solutions. Our ambition is to develop and clinically validate therapeutic assets, particularly in oncology. Our first candidate is a peptide derived from sortilin that targets lung adenocarcinoma.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Yomi Pharma has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Yomi Pharma has never raised funding before.
Netherlands
United Arab Emirates
South Africa
United States
Sweden
Frequently asked questions
Yomi Pharma is located in Limoges, Nouvelle-Aquitaine, FR.
Yomi Pharma generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
Yomi Pharma has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Yomi Pharma was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
Yomi Pharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
